PF-06863135 As Single Agent And In Combination With Immunomodulatory Agents In Relapse/Refractory Multiple Myeloma
Clinical trial NCT03269136 · COMPLETED
Trial details
- NCT number
- NCT03269136
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-29
- Primary completion
- 2024-01-19
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.